Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Cost of Revenue (2020 - 2026)

Updated

Pharming's Cost of Revenue came in at $21.19 million for Q2 2026, up 22.5% from $17.3 million a year earlier and up 218.9% from the prior quarter.

Analysis

Pharming (PHAR) Cost of Revenue (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Pharming reported Cost of Revenue of $80.43 million, up 18.6% year-over-year; for FY2025, it came in at $45.5 million, up 28.5% from FY2024.

  • Cost of Revenue has increased in each of the last three years, with a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $35.4 million in FY2024 (+40.4%), $25.21 million in FY2023 (+43.6%), $17.56 million in FY2022 (-16.9%) and $21.14 million in FY2021 (-10.2%).
  • The five-year range for quarterly Cost of Revenue is -$14.78 million (Q4 2021) to $50.1 million (Q2 2022).
  • Year-over-year, Cost of Revenue increased in five of the last eight quarters, with growth averaging 7.8%.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q2 2022 (growth of 992.2%), and the weakest in Q2 2023 (a decline of 80.4%).
  • Business Quant data shows PHAR's Cost of Revenue at $6.64 million (Q1 2026), $45.5 million (Q4 2025) and $7.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn 21.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.19 Mn
Mar 31, 2026 6.64 Mn
Dec 31, 2025 45.50 Mn
Sep 30, 2025 7.10 Mn
Jun 30, 2025 17.30 Mn
Mar 31, 2025 8.32 Mn
Dec 31, 2024 35.40 Mn
Sep 30, 2024 6.80 Mn
Jun 30, 2024 16.37 Mn
Mar 31, 2024 8.39 Mn
Dec 31, 2023 25.21 Mn
Sep 30, 2023 8.30 Mn
Jun 30, 2023 9.80 Mn
Mar 31, 2023 4.08 Mn
Dec 31, 2022 6.30 Mn
Sep 30, 2022 2.30 Mn
Jun 30, 2022 50.10 Mn
Mar 31, 2022 4.90 Mn
Dec 31, 2021 -14.78 Mn
Sep 30, 2021 5.98 Mn
API Access

Pharming Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PHAR&period=max&api_key=YOUR_API_KEY